rs28399504
Clopidogrel (Plavix®) |
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | 0 | normal |
(A;G) | 2 | carrier of a CYP2C19*4 allele, considered a "slow metabolizer" variant |
(G;G) | 2.5 | poor metabolizer |
Reference | GRCh38 38.1/141 |
Chromosome | 10 |
Position | 94762706 |
Gene | CYP2C19 |
is a | snp |
is | mentioned by |
dbSNP | rs28399504 |
dbSNP (classic) | rs28399504 |
ClinGen | rs28399504 |
ebi | rs28399504 |
HLI | rs28399504 |
Exac | rs28399504 |
Gnomad | rs28399504 |
Varsome | rs28399504 |
LitVar | rs28399504 |
Map | rs28399504 |
PheGenI | rs28399504 |
Biobank | rs28399504 |
1000 genomes | rs28399504 |
hgdp | rs28399504 |
ensembl | rs28399504 |
geneview | rs28399504 |
scholar | rs28399504 |
rs28399504 | |
pharmgkb | rs28399504 |
gwascentral | rs28399504 |
openSNP | rs28399504 |
23andMe | rs28399504 |
SNPshot | rs28399504 |
SNPdbe | rs28399504 |
MSV3d | rs28399504 |
GWAS Ctlg | rs28399504 |
GMAF | 0.001377 |
Max Magnitude | 2.5 |
This SNP has been recognized by the Coriell Personalized Medicine Collaborative ICOB.
|
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
rs28399504 is a SNP in the CYP2C19 gene, potentially encoding the CYP2C19*4 variant. This variant has been linked to poor metabolism of compounds like mephenytoin. It is also known as M1V or Met1Val.[PMID 9435198]
The risk allele is rs28399504(G).
As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid).
According to a 23andMe discussion This is one of the SNPs which were re-analyzed April 2009. Customers with older data may wish to redownload. SNPs effected rs4420638, rs34276300, rs3091244, rs34601266, rs2033003, rs7900194, rs9332239, rs28371685, rs1229984, and rs28399504.
[PMID 21247447] CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population
ClinVar | |
---|---|
Risk | Rs28399504(G;G) rs28399504(T;T) |
Alt | Rs28399504(G;G) rs28399504(T;T) |
Reference | Rs28399504(A;A) |
Significance | Other |
Disease | Mephenytoin clopidogrel response - Efficacy not provided |
Variation | info |
Gene | CYP2C19 |
CLNDBN | Mephenytoin, poor metabolism of clopidogrel response - Efficacy not provided |
Reversed | 0 |
HGVS | NC_000010.10:g.96522463A>G |
CLNSRC | OMIM Allelic Variant PharmGKB Clinical Annotation |
CLNACC | RCV000018399.28, RCV000211166.1, RCV000383294.1, |
[PMID 18547414] Genotyping panel for assessing response to cancer chemotherapy.
[PMID 23130019] Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.